Dr. Kreton Mavromatis, of Emory University and Atlanta VA Medical Center, discusses with Dr. Ron Waksman an analysis of the ISCHEMIA trial evaluating quality of life for patients who underwent complete revascularization with those who underwent more conservative treatment. This analysis, which was presented as a late-breaking trial at ACC.21 Virtual, found that complete revascularization generally resulted in greater improvement in angina-related quality of life than incomplete revascularization, particularly in patients who began the study experiencing angina on a daily or weekly basis.
